Retatrutide / Cagrilitide 10 mg + 5 mg research-grade lyophilized powder supplied in a sealed glass vial. This dual-compound formulation is studied in experimental models of metabolic regulation, appetite signaling and energy balance via incretin and amylin-related pathways.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Purity
High-purity research grade
Content
Retatrutide 10 mg + Cagrilitide 5 mg (15 mg total) per vial
Total content
15 mg combined lyophilized peptide
Packaging
Sealed glass vial with sterile stopper
Storage
Store in a cool, dry place. Recommended storage below 18 °C.
Molecular formula
Not specified (peptide compounds)
Molecular weight
Not specified (peptide compounds)
IUPAC name
Retatrutide; Cagrilitide
CAS number
Retatrutide: 2381089-83-2
Cagrilitide: 1415456-99-3
Research Overview
Retatrutide and cagrilitide are synthetic peptide analogues studied in advanced metabolic research. Retatrutide is investigated for its multi-receptor activity within incretin pathways, while cagrilitide is explored as a long-acting amylin analogue. In experimental settings, this combination is used to study appetite regulation, energy expenditure, glucose handling and metabolic signaling integration.
Primary Research Areas
-
Incretin & amylin signaling pathways: used to investigate combined modulation of GLP-1, GIP, glucagon and amylin-related receptor systems in metabolic research models.
-
Energy balance & appetite regulation: applied in experimental studies examining food intake behavior, satiety signaling and central–peripheral metabolic communication.
-
Glucose metabolism & insulin dynamics: explored in preclinical models assessing glycemic control, insulin sensitivity and pancreatic signaling responses.
-
Body-weight regulation models: studied in animal models of obesity and metabolic dysfunction to evaluate synergistic effects on adiposity and energy expenditure.
-
Neuroendocrine & metabolic integration: investigated for interactions between central appetite circuits, peripheral hormone signaling and adaptive metabolic responses.
